This is a community-generated profile. If you would like to claim it, please .
OvaScience careers
Fertility decreases with age. Mitochondria are the primary source of cellular energy from within eggs, and this energy is a key determinant of egg quality. It has been demonstrated that the number and function of mitochondria decrease with age. With OvaScience’s innovative scientific approach, a woman’s eggs may be rejuvenated by injecting fresh mitochondria isolated from her own egg precursor cells into her egg during IVF. This has the potential to improve egg quality and thereby increase the success of IVF. With higher quality eggs, there is also the potential to transfer fewer embryos, which can result in a lower incidence of conceiving multiples (twins or triplets) and resulting complications. The company’s technology is designed to enhance the current standard of care in IVF and can be measured by well-accepted endpoints.
OvaScience hasn't added any jobs yet
Get notified when OvaScience posts new jobs.
sefgh dgfvdfg
Worked at OvaScience
Andrew Judd
Worked at OvaScience, Department of Biochemistry University of Toronto. Went to University of Toronto, University of Guelph
Sarah Myers
HR Associate at OvaScience
Total raised
$82M
Funded over
5 rounds
Latest round
IPO (May 2013)
Alexza Pharmaceuticals • Fremont • 6 days ago
RF Venue • Walpole • 7 days ago
Ptc Therapeutics • United States • $139k – $175k • 7 days ago
Pfizer • New York City • $124k – $207k • 1 week ago
Emerald Therapeutics • Austin • 1 week ago

